ABBEY DICHIARA: Open Payments
NPI 1275907354 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 31 payments from 8 companies in 2025. Trend: 2023 $1,056 · 2024 $804 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $163 |
| Novartis Pharmaceuticals Corporation | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Amgen Inc. | 3 | $42 |
| PFIZER INC. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: LEQVIO, WAINUA, VERQUVO, Repatha, ACCOLADE SR, LATITUDE Communicator Power Supply, VYNDAQEL, ELIQUIS.
Industry payments across MS — which companies pay providers there.
